Helix BioPharma Market Cap

Helix BioPharma has a market cap or net worth of $33.52 million as of January 27, 2025. Its market cap has decreased by -12.76% in one year.

Market Cap

33.52M

Enterprise Value

33.36M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.45

Market Cap Chart

Since August 15, 1995, Helix BioPharma's market cap has increased from 6.90M to 33.52M, an increase of 386.13%. That is a compound annual growth rate of 5.51%.

Market Cap History

Date	Market Cap	% Change
Jan 24, 2025	33.52M	10.56%
Dec 31, 2024	30.32M	-11.99%
Dec 29, 2023	34.45M	8.43%
Dec 30, 2022	31.77M	-5.92%
Dec 31, 2021	33.77M	-36.31%
Dec 31, 2020	53.03M	-58.92%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	2.02B
Veradigm	1.31B
SS Innovations International	1.20B
Nika Pharmaceuticals	605.85M
Elite Pharmaceuticals	523.50M
Glass House Brands	466.41M
Northwest Biotherapeutics	416.19M
CytoDyn	268.61M

Market Cap Rankings